This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

National Cooperative Growth Study in CKD (NCGS)

This study has been completed.
Genentech, Inc.
Information provided by (Responsible Party):
University of California, Davis Identifier:
First received: February 4, 2008
Last updated: May 25, 2017
Last verified: May 2017
The purpose of this study is to learn whether growth hormone being administered to children with Chronic Kidney Disease is effective and if it has any side effects.

Growth Hormone Deficiency

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: National Cooperative Growth Study of Nutropin AQ, Nutropin, Protropin, and Nutropin Depot in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End-Stage Renal Disease (ESRD)

Resource links provided by NLM:

Further study details as provided by University of California, Davis:

Primary Outcome Measures:
  • The primary outcome measures of the NCGS are ongoing safety and efficacy of Genentech GH preparations in pediatric growth disorders for which GH is initiated. [ Time Frame: per the study, the pt will be on GH treatement until the physician instructs them to stop ]

Enrollment: 27
Study Start Date: October 2005
Study Completion Date: February 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
pediatric clinic

Inclusion Criteria:

  • Must be a patient of the UC Davis Medical Center pediatric clinic with Chronic Kidney Disease

Exclusion Criteria:

  • Greater than 18 years old
  • Not a patient at the UC Davis Medical Center pediatric clinic
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00616278

United States, California
UC Davis Medical Center
Sacramento, California, United States, 95817
Sponsors and Collaborators
University of California, Davis
Genentech, Inc.
Principal Investigator: Lavjay Butani, M.D. University of California, Davis
  More Information

Responsible Party: University of California, Davis Identifier: NCT00616278     History of Changes
Other Study ID Numbers: 200412150
Study First Received: February 4, 2008
Last Updated: May 25, 2017

Keywords provided by University of California, Davis:
Growth Failure AND
Chronic Renal Insufficiency OR
End Stage Renal Disease

Additional relevant MeSH terms:
Kidney Failure, Chronic
Renal Insufficiency
Dwarfism, Pituitary
Renal Insufficiency, Chronic
Kidney Diseases
Urologic Diseases
Bone Diseases, Developmental
Bone Diseases
Musculoskeletal Diseases
Bone Diseases, Endocrine
Pituitary Diseases
Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases processed this record on September 20, 2017